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Epilepsy surgery is highly eﬀective in treating refractory epilepsy, but requires accurate presurgical localization of the epileptogenic
focus. Brieﬂy, localization of the region of seizure onset traditionally dependents on seizure semiology, scalp EEG recordings and
correlation with anatomical imaging modalities such as MRI. The introduction of noninvasive functional neuroimaging methods,
including single-photon emission computed tomography (SPECT) and positron emission tomography (PET) has dramatically
changedthemethodforpresurgicalepilepsyevaluation.Theseimagingmodalitieshavebecomepowerfultoolsfortheinvestigation
of brain function and are an essential part of the evaluation of epileptic patients. Of these methods, SPECT has the practical
capacity to image blood ﬂow functional changes that occur during seizures in the routine clinical setting. In this review we present
thebasicprinciplesofepilepsySPECTandPETimaging.WediscussthepropertiesoftheSPECTtracerstobeusedforthispurpose
and imaging acquisition protocols as well as the diagnostic performance of SPECT in addition to SPECT image analysis methods.
This is followed by a discussion and comparison to F-18 FDG PET acquisition and imaging analysis methods.
1.Introduction
Epilepsy surgery can be highly eﬀective in treating refractory
epilepsy if performed in properly selected patients with well-
delineated ictal foci [1]. The greatest challenge is accurate
localization, but only a small fraction of the patients whose
epilepsy becomes refractory ultimately receive surgery. In the
past, localization of the region of seizure onset was depen-
dent upon scalp, cortical, and depth electroencephalography
(EEG).However,scalpEEGhasdisadvantagessuchasdepen-
dency on cortical surface eﬀects and low spatial resolution
that can lead to mislocalization of epileptogenic foci. Both
cortical and depth EEG have a limited spatial sampling area
that is conﬁned to regions accessible by electrode placement.
Depth EEG can detect signals from deeper structures, but it
is more invasive, which can lead to surgical complications
[2].
The introduction of noninvasive neuroimaging meth-
ods, such as single-photon emission computed tomography
(SPECT), positron emission tomography (PET), and mag-
netic resonance imaging (MRI), has dramatically changed
presurgicalepilepsyevaluation.Theseimagingmethodshave
becomepowerfultoolsfortheinvestigationofbrainfunction
and an essential part of the evaluation of epileptic patients.
Of these methods, only SPECT has the practical capacity
to image blood ﬂow functional changes that occur during
seizures in the routine clinical setting. Although functional
MRI (fMRI) could, in theory, be used for this purpose, it
is impractical due to patient movement during most types
of seizures, a problem that is overcome by the timing and
technique of SPECT imaging.
In this paper, we review basic principles of epilepsy
SPECT, SPECT tracers, imaging acquisition, the diagnostic
performance of SPECT, and imaging analysis methods. This2 International Journal of Molecular Imaging
is followed by a discussion and comparison to PET tracer
acquisition methods and imaging analysis methods.
2. Central Nervous System
Radiopharmaceuticals for SPECT
SPECT radiopharmaceuticals used for measuring regional
cerebral blood ﬂow (rCBF) are lipophilic agents which are
transported from the vascular compartment to the normal
brain tissue compartment by diﬀusion and are distributed
proportionally to regional tissue blood ﬂow. After this ﬁrst
phase of transport (during the ﬁrst pass through the brain),
the tracer is essentially irreversibly trapped in the tissue
compartment and does not change its relative distribution
over time. These properties are essential in ictal SPECT, since
the tracer is essentially trapped during the ﬁrst few seconds
after injection and maintains that distribution for hours,
allowing the patient to be stabilized and imaged at rest, but
the emission of photons still reﬂects the tracer distribution
pattern seconds after injection. The two major blood ﬂow
agents used in brain SPECT imaging are technetium-99m
hexamethyl-propylene amine oxime (Tc-99m HMPAO) and
Tc-99m ethyl cysteinate dimer (Tc-99m ECD) [3, 4].
2.1.Tc-99mHexamethyl-propyleneAmineOxime(HMPAO).To
understand the uptake mechanism of Tc-99m hexamethyl-
propylene amine oxime (Tc-99m HMPAO), a three-compar-
tment analysis model can be used for analysis [5]. In this
model the ﬁrst compartment is the lipophilic tracer in the
blood pool of the brain, but outside of the blood brain-bar-
rier. The second compartment is comprised of the lipophilic
tracer inside of the blood brain-barrier. The third compart-
ment is the hydrophilic form of the tracer that is retained
in the brain. Transport from the ﬁrst compartment to the
second compartment represents eﬄux of lipophilic tracer
from the blood compartment to the brain compartment.
Back-exchange from the third compartment to the second
compartment represents back-diﬀusion of the lipophilic
form of the tracer and is essentially equal to zero since the
tracer is irreversibly trapped (by intracellular reaction with
glutathione) in the brain.
2.2. Tc-99m Ethyl Cysteinate Dimer (ECD). The second
tracer commonly used in brain SPECT to measure regional
c e r e b r a lp e r f u s i o ni sT c - 9 9 mE C D[ 6]. This radiophar-
maceutical is lipophilic like Tc-99m HMPAO and rapidly
traverses the endothelium and capillary membranes into the
brain cells. However, in the third compartment irreversible
trapping mechanism of this tracer diﬀers from Tc-99m
HMPAO, since Tc-99m ECD is enzymatically metabolized
to a polar complex, which is trapped in the brain. This
tracer has been reported to demonstrate less nonspeciﬁc
scalp and facial tissue background activity compared with
Tc-99m HMPAO. Figure 1 shows a normal Tc-99m ECD
brain SPECT scan after injection of 20mCi (740MBq) I.V.
2.3. Diﬀerences in Cerebral Distribution of Tc-99m HMPAO
and Tc-99m ECD. Several studies reported higher extracere-
bral background activity with Tc-99m HMPAO than with
Normal Tc-99m ECD brain scan
Figure 1: Transverse tomographic images from a normal 41-year-
old female subject after injection of 20mCi Tc-99m ECD. The
transverseimagesarearrangedparalleltoandsequentiallyabovethe
canthomeatal line, with the cerebellum at the top left and the vertex
of the brain at the bottom right. The scan thickness is 4mm. The
scan resolution is approximately 7mm full width at half maximum.
Tc-99m ECD due to the slower clearance rate of Tc-99m
HMPAO from the blood [7–10]. This can contribute to a
lowering of the cortical uptake to background ratio with
subsequent decreased detectability of epileptogenic focus.
Additionally, Tc-99m HMPAO tends to underestimate the
high ﬂow rate due to a nonlinear extraction pattern to the
ﬂow whereas Tc-99m ECD reﬂects rCBF more linearly than
Tc-99m HMPAO at higher ﬂow rates [11]. Therefore, Tc-
99mECDmaybemoresensitiveindetectingahyperperfused
epileptogenic focus at a high ﬂow rate.
2.4. Comparison of Radiopharmaceutical Diagnostic Perfor-
mance of Tc-99m HMPAO versus Tc-99m ECD. Lee et al.
demonstrated that Tc-99m HMPAO has a similar localiza-
tion rate (82%) to that of Tc-99m ECD (71%) in patients
with TLE (in this group a total of 17 patients had Tc-99m
HMPAO SPECT and 7 patients had Tc-99m ECD SPECT),
with a higher degree of hyperperfusion in the Tc-99m
HMPAO group [12]. For patients with neocortical epilepsy
(23 patients had Tc-99m HMPAO SPECT and 7 patients
had Tc-99m ECD SPECT), there was a higher localization
rate (70% versus 29%) and degree of hyperperfusion in the
Tc-99m HMPAO group. The authors summarized that the
sensitivity of Tc-99m ECD ictal SPECT is similar to that
o fT c - 9 9 mH M P A Oi c t a lS P E C Ti nT L E .H o w e v e r ,i c t a l
hyperperfusionwashigherwiththeTc-99mHMPAOSPECT
in patients with neocortical epilepsy. Tc-99m HMPAO ictal
SPECT also was superior to Tc-99m ECD ictal SPECT in
sensitivity and degree of hyperperfusion. They concluded
that the diagnostic performance and contrast of hyperper-
fused areas at the epileptogenic zones of Tc-99m HMPAO
ictal SPECT were better than those of the Tc-99m ECD ictal
SPECT in their group of patients.
3. Image Acquisition
3.1. SPECT Image Acquisition. In-single photon emission
computed tomography (SPECT) of the brain, dual andInternational Journal of Molecular Imaging 3
triple-head Anger gamma cameras are now in common use
and can provide very high resolution images (approximately
sevenmillimeters fullwidthhalfmaximum(FWHM)extrin-
sic resolution) [13]. The resolution has improved, primarily,
due to the increased count detection capability of these
cameras. In addition, these cameras allow faster throughput
of patients since the scan time can be decreased. Scanning
can be performed in temporal segments, with summation
of the projection images at the end of acquisition. This
enables salvaging of studies in which patient motion might
occur. For example, a 30-minute scan can be divided into
two 15-minute segments, each obtaining a 360◦ set of
projection images. If the patient moves during the last
15-minute imaging segment, the ﬁrst 15-minute imaging
segment can be used for reconstruction of the complete set
of tomographic images.
3.2. Ictal SPECT: Practical Issues. In order to perform these
studies, Tc-99m HMPAO must be readily available at the
patient’s bedside allowing for rapid injection by a trained
technologist or other personnel immediately available at the
timeofseizureonset.Theictalinjectionshouldbeperformed
in a rapid bolus fashion such that the entire tracer is injected
during the ﬁrst onset of seizure (ictus). The patient is then
sedated and transferred to the SPECT scanner within several
hours to acquire the brain SPECT scan which will indicate
the regional cerebral perfusion at the time of ictus. This
method is feasible since Tc-99m HMPAO is irreversibly
trapped in the epileptogenic hyperemic region at the time
of seizure, and during the period between injection and
scan, there is essentially no redistribution. The subsequent
scan (albeit several hours after the injection) will still show
hyperemia (increased tracer counts) in the region of the
epileptogenic focus.
4. DiagnosticPerformance of Ictal and
Interictal SPECT
The sensitivity of ictal SPECT is theoretically higher than
that of interictal SPECT because of the large CBF increase
fromthebaselinethatoccursduringtheictalphase[14].This
is a substantially larger perfusion diﬀerence (approximately
50%) than from the 0–10% to at most 40% reduction of
ﬂow seen during the interictal phase [15, 16]. A comparison
between ictal and interictal SPECT is shown in Figure 2.
Several prior studies have shown a diﬀerence in sensitivity
between ictal and interictal SPECT [17]. Overall, the highest
sensitivity was seen in ictal SPECT (97% to 100%), followed
by postictal SPECT (75% to 77%). Interictal SPECT was
shown to have the lowest sensitivity (43% to 44%).
Figure 3 illustrates the value of ictal SPECT in a nine-
year-old right-handed boy who had a seven-year history of
intractable seizures. The ﬁgure shows a Tc-99m HMPAO
brain SPECT scan which was performed 2 hours after tracer
injection. The tracer was injected at the bedside 3 seconds
after seizure onset (the seizure lasted ∼25 seconds). The ictal
SPECT scan shows a focal area of intense uptake in the right
frontal lobe. Computed tomography (CT) and magnetic res-
onance imaging (MRI) studies carried out at our and other
Intractable epilepsy with normal MRI
Ictal Interictal
Figure 2: Illustration of the value of ictal SPECT in a 38-year-
old male with intractable epilepsy. The MRI was normal. The
Tc-99m HMPAO ictal brain SPECT scan showed a focal area of
hyperperfusion in the right frontal area. In this case, the interictal
scan shows normal perfusion to this area of the brain.
Epilepsy
MRI Tc-99m HMPAO
rCBF SPECT MRI-SPECT fusion
RRR LL L
Figure 3:Tc-99mHMPAOictalbrainSPECTscansection(middle)
showing a focal area of hyperperfusion in the right premotor area.
The right to left asymmetry in blood ﬂow for this region was 1.32,
and the intensity of uptake in the right frontal lobe measured 1.13
(cortical to cerebellar ratio) with a range of normals = mean ± 1SD
of 0.90 ± 0.07. The ictal brain SPECT scan was subsequently coreg-
istered with the MRI scan (left). The resulting fusion image (right)
shows the anatomic location of the epileptogenic focus, which was
surgically excised, and the patient was rendered seizure-free.
institutions were normal. Multiple EEG investigations were
inconclusive. Previous EEGs revealed infrequent slowing
over the right hemisphere. Multiple video EEG monitoring
studies performed at our and other institutions showed
stereotypical seizures with no ictal scalp localization. Inter-
ictal activity revealed occasional sharp discharges involving
the right frontal central parietal regions.
5. ImagingAnalysisandInterpretation
5.1. Methods of Ictal-Interictal SPECT Subtraction. The tra-
ditional qualitative visual analysis of a SPECT perfusion
study involves comparison of each cerebral region with the
contralateral side. Limitations of interpretation of SPECT
by conventional visual assessment include diﬃculty in the4 International Journal of Molecular Imaging
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Figure 4: An interictal technetium-99m ECD brain SPECT scan
(top)ascomparedwithanictaltechnetium-99mECDbrainSPECT
scan (second row). On the ictal brain SPECT scan one can see
increased hyperemia involving the left temporal lobe (third and
fourth rows). Using subtraction comparison, one can see statis-
tically signiﬁcant diﬀerences between the ictal and interictal scan
involving the left temporal lobe. The test for statistical signiﬁcance
has z values between three and four (red color = z value of 4).
detection of subtle changes that can be associated with
inhomogeneous baseline perfusion patterns, variation in
the amount of injected radioisotope, time of injection, and
patient positioning [18]. Also, the interpretation can be
subjective, depending on the readers, which can create inter-
observerandevenintraobservervariability.Inaddition,ifthe
epileptogenic zone is hypoperfused at baseline (interictal),
the ictal increase in tracer uptake may be obscured (i.e.,
appear normal) despite relative hyperperfusion [19].
Foramoreobjectiveandquantitativeanalysis,Zubaletal.
proposed a subtraction method in which coregistered ictal
and interictal images were normalized based on total pixel
countsinthebrainandthensubtractedfromeachother[20].
Therefore, each pixel represented the percent diﬀerence
between two data sets (ictal and interictal). Overall, subtra-
ction analysis had a higher concordance rate with the out-
come“goldstandard”(successfulsurgicaloutcomeorintrac-
ranial EEG) compared with conventional side-by-side visual
analysis of ictal (or peri-ictal) and interictal SPECT [21–24].
Another subtraction method proposed by O’Brien et al. is
SISCOM (subtraction ictal SPECT coregistered to MRI)
which also demonstrates similar results with a signiﬁcantly
higher concordance rate than visual analysis [19]. This inclu-
des the following steps: (1) SPECT to SPECT coregistration
with distance-based surface matching technique, (2) SPECT
normalization, (3) SPECT subtraction and thresholding,
and (4) subtraction SPECT to MRI coregistration [19].
Figure 4 shows ictal-interictal subtraction images from a
R.C.
56 Y/O F
F-18 FDG brain PET: normal
Figure 5: Normal F-18 FDG PET image from a 56-year-old
female subject at rest. PET scan image slice thickness of ∼4mm
reconstructed in plane image resolution = 5mmFWHM.
39-year-old male with a history of refractory complex partial
epilepsy for 25 years. His MRI scan has been consistently
normal. Interictal SPECT showed hypometabolism of the
left temporal region while ictal SPECT showed increased
rCBF in both the lateral and mesial left temporal lobe.
Subtraction analysis clearly showed that there was increased
left temporal rCBF (z score >+3).
5.2. Statistical Parametric Mapping (SPM). Statistical para-
metric mapping refers to the construction and assessment of
spatiallyextendedstatisticalprocessesusedtotesthypotheses
about functional imaging data. In rCBF SPECT or F-18
FDG PET image data analysis, this translates to methods
to test hypotheses about regionally speciﬁc eﬀects (e.g., the
probability of ﬁnding a region of increased regional cerebral
perfusion or metabolism by chance). When two image data
sets are evaluated by SPM, all voxels contained within the
scans are compared in the same space on a voxel-by-voxel
basis using linear constraints to test hypotheses for speciﬁc
focal eﬀects using a univariate statistical test. The resulting
statistical parameters are then assembled onto an image
(i.e., the statistical parametric map). Diﬀerences of one
map compared with the map derived from the other scans
are interpreted as regionally speciﬁc eﬀects, attributable to
some alteration in brain function from one scan to the
other. The signiﬁcance of these diﬀerences is assessed using
statistical tests (usually the t or F statistic). Criteria for
accepting voxels (those intended to represent true changes
in regional cerebral perfusion) can be set for voxel height
(p) and extent of contiguous cluster of voxels (k). For
visualizationoftheresults,apseudocolorscalecanbeapplied
to accepted signiﬁcant voxels, which are then overlaied
in a semitransparent fashion onto the MRI of either the
normative atlas or the patient’s own MRI anatomy. The most
recent version of SPM (SPM2) combines the general linear
model to create the statistical map and the random ﬁeld
theory to make statistical inference about regional eﬀects.
Software for SPM analysis is available as Freeware from the
Welcome Department of Imaging Neuroscience (UniversityInternational Journal of Molecular Imaging 5
College London, London, UK). Although the SPM package
includes most of the programs required for image processing
and analysis, visualization of images and some processing or
image editing and reformatting may require more dedicated
biomedical image processing software.
The use of SPM image analysis is now increasingly be-
ing applied in the clinical diagnosis of neuroimaging of
numerous disorders including epilepsy. An ictal SPECT
scan can be compared with the interictal SPECT scan and
correlated with a normal brain SPECT atlas using SPM to
identify regions of signiﬁcant alterations in regional cerebral
blood ﬂow related to seizure activity and localize these
regions in Montreal Neurological Atlas space. If regions of
maximalictalcerebralbloodﬂowcanbereliablyidentiﬁedby
this method, fully objective ictal rCBF SPECT analysis can be
made widely available for clinical use. Recent studies support
SPM analysis of ictal SPECT scans [25].
6. The Role of F-18 FDG PET inthe
Evaluation of Epilepsy
6.1. A Second Major Class of Radiopharmaceuticals Are Those
ThatMeasureBrainMetabolism. Theseradiopharmaceuticals
aretransportedtothebraintissuesbyregionalcerebralblood
ﬂow, but subsequent regional cerebral distribution reﬂects
the utilization rate of the tracer in a cerebral metabolic
pathway. The PET radiopharmaceutical predominantly used
is F-18 ﬂuorodeoxyglucose (F-18 FDG) [26]. Figure 5 illus-
trates a normal F-18 FDG PET scan.
6.2. F-18 FDG PET Image Acquisition. Approximately
10mCi F-18 FDG I.V is injected. The tomograph should be
of the latest generation, multislice to cover the entire brain.
The 3D acquisition mode should be used to accommodate
lower dosimetry and to improve the count statistics of the
data. Measured attenuation correction should be employed.
Theimageshouldbereconstructedwiththestandardclinical
reconstruction including all necessary corrections (random,
scatter,attenuation).Asetofcalibrationphantomsincluding
at the minimum the Hoﬀman brain phantom and the
uniformcylindershouldberunperiodicallytoassessscanner
stability (qualitative and quantitative, resp.).
Subject conditions during the performance of PET scans
should be fully characterized and standardized whenever
possible. PET studies should be performed during “a resting
state” (e.g., eyes open, ears unoccluded in a dark room
with minimal ambient noise). Procedures to minimize
head movement during scans should be implemented using
well-tolerated head immobilization procedures. The use of
medications and the behavioral state of patients at the time
of the scan also should be carefully considered.
6.3. F-18 FDG PET Utility in Epilepsy. F-18 FDG PET is
typicallyseeninpatientswithhippocampalsclerosisonMRI.
This is illustrated in Figure 6 in a 16-year-old boy with
temporallobeepilepsyandhippocampalsclerosisintheright
mesial temporal lobe on MRI. The MRI shows abnormal
high signal intensity in the right hippocampal region. The
FDG PET shows a corresponding area of focal reduction
of FDG uptake in the right hippocampal region. After left
temporal lobectomy, the patient was rendered seizure free.
Presurgical evaluation and the surgical treatment of non-
lesional neocortical epilepsy is one of the most challenging
areas in epilepsy surgery. Fluorodeoxyglucose (FDG) PET
shows hypometabolism in a majority of patients with non-
lesional temporal lobe epilepsy (TLE), even in the absence
of hippocampal atrophy. In extratemporal epilepsy where
the MRI scan is normal, there is a less likely chance to ﬁnd
the epileptogenic focus by F-18 FDG PET hypometabolism
alone.Figure 7showsanexamplewheretheMRIwasnormal
in a 2-year-old female with intractable partial epilepsy and
developmental delay where the F-18 FDG PET unequivocally
identiﬁed the epileptogenic focus. EEG showed frequent and
focal discharges from the right central parietal region. In
this case the F-18 FDG localized the epileptogenic region
suitable for grid placement and invasive intracranial EEG
monitoring.
InterictalFDGPETstudieswillhavelimitedusefulnessin
the presence of multiple hypometabolic regions in patients
with multifocal brain syndromes, such as in children with
tuberous sclerosis. Such children with multifocal lesions
represent a special challenge during presurgical evaluation.
Thegoaloffunctionalimaginginthesecasesistoidentifythe
epileptogenic lesions and diﬀerentiate them from nonepilep-
togenic ones. In this context, ictal rCBF SPECT may have
useful clinical applications but may be technically challeng-
ing when seizures are short, as is particularly common in
frontal lobe epilepsy and in children who have infantile
spasms that are associated with multifocal cortical dysplasia
[27]. Figure 8 illustrated F-18 FDG PET ﬁndings in a 1-
year-old boy with tuberous sclerosis who underwent a PET-
CT scan. Anatomically there were several lesions that were
abnormal even on the CT portion of the PET-CT scan. These
areas also showed reduced FDG uptake on PET. Ictal SPECT
was able to identify the dominant area of presumed epilepto-
genesis associated with a large tuber in the right frontal lobe.
6.4. Outcome Prediction Using FDG PET. Although FDG
PET images can be analyzed visually, additional information
can be obtained by semiquantitative analysis, such as left-
to-right asymmetry indices. Semiquantitative analysis using
theasymmetryindexisgenerallyconsideredsigniﬁcantwhen
ad i ﬀerence of 15% or greater exists between the aﬀected
and contralateral sides [28]. Quantitative asymmetry indices
should reduce potential error due to the misinterpreting of
these normal left-to-right variations [29]. Registration pro-
grams can be used to align structural MRI and PET for more
precise anatomic localization of the hypometabolic area.
Althoughregionalhypometabolismistypicallypresentin
the temporal lobe ipsilateral to EEG seizure onset, other
brain regions may also show patterns of glucose hypome-
tabolism [30]. For example, a FDG PET study of patients
with temporal lobe epilepsy demonstrated hypometabolic
regions ipsilateral to seizure onset that included lateral
temporal (in 78% of patients), mesial temporal (70%),
thalamic (63%), basal ganglia (41%), frontal (30%), parietal
(26%), and occipital (4%) regions [30]. In pure TLE,
however, the extratemporal hypometabolic regions rarely6 International Journal of Molecular Imaging
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Figure 6: 16-year-old boy with temporal lobe epilepsy and hippocampal sclerosis in the right mesial temporal lobe on MRI. (a) MRI shows
abnormal high signal intensity in the right mesial temporal lobe (hippocampal region). (b) FDG PET scan shows a focal reduction of
FDG uptake in the right mesial temporal lobe (hippocampal region). (c) MRI-PET fusion image illustrating that the reduction in FDG
corresponds to the region of MRI increase in signal intensity.
(a)
>
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>
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>
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Figure 7: Two-year-old female with intractable partial epilepsy and developmental delay. (a) MRI is normal. (b) Focal F-18 FDG reduction
in the right superior parietal lobe representing the epileptogenic focus (arrowhead). (c) MR-PET fusion image. Focal FDG reduction in the
right superior parietal lobe representing the epileptogenic focus (arrowhead). (d) 3D-SSP map shows signiﬁcant reduction of F-18 FDG
(arrowhead). (e) Placement of intracranial electrodes guided by F-18 FDG PET is shown on skull radiograph.
show epileptiform activity on EEG but may be aﬀected
by rapid seizure propagation [30]. Unilateral temporal
hypometabolism predicts good surgical outcome from tem-
poral lobectomy, and the greater the metabolic asymmetry,
the greater the chance of becoming seizure-free [31].
7.MultimodalImaginginEpilepsy
7.1. Interictal SPECT versus Interictal PET. FDG PET reﬂects
glucose metabolism of the brain as an indirect measure of
neuronal function while SPECT represents cerebral blood
ﬂow changes. Although PET has higher spatial resolution
and lower background activity, one of the limitations of
FDG-PET for the evaluation of epilepsy during the ictal
phase is its low temporal resolution. This is due to a tracer
uptake period (30–45 minutes) that is signiﬁcantly longer
than the average seizure duration (1-2 minutes), which leads
to a mixture of interictal-, ictal-, and postictal-phase images,
and this makes only interictal PET feasible. FDG is glucose
analogue which is actively transported into metabolically
active cells and then temporarily held in the intracellular
space due to phosphorylation by hexokinase. However,
this is a reversible event, and FDG uptake is both slower
and shorter lasting than incorporation of SPECT tracers.
Therefore, PET is used to obtain clinical information during
the interictal phase. The sensitivity of interictal PET is higher
than that of interictal SPECT, as described in a previous
meta-analysis by Spencer [32]. One potential explanation for
this is the uncoupling of blood perfusion and metabolism,
in which there is more reduction in regional cerebral glucose
metabolic rates than in regional cerebral perfusion. Evidence
for this uncoupling was demonstrated in prior studies using
O-15 H2O and F-18 FDG PET [33, 34] and using ratio
imaging of interictal Tc-99m HMPAO SPECT divided by F-
18 FDG-PET [35, 36].
7.2. Ictal SPECT versus Interictal PET. Ictal SPECT and
interictal FDG-PET were found to have similar sensitivityInternational Journal of Molecular Imaging 7
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Figure 8: F-18 FDG PET ﬁndings in a 1-year-old boy with tuberous sclerosis. (a) FDG PET portion of PET-CT scan showed reduced
metabolism in the multiple areas of the tubers, with signiﬁcant reduction in the focus in the right parasagittal frontal lobe (arrow). (b) CT
portionofPET-CTscanshowingsclerosisintheregionoftherightparasagittalfrontallobetuber(arrow).(c)PET-CTfusionimageshowing
that the areas of decreased metabolism correspond to the prominent right parasagittal frontal lobe tuber.
(a) (b) (c)
Figure 9: 42-year-old female with intractable seizures with seizure activity frequency of 1-2 brief seizures per day, felt to arise from the
frontal lobe regions, but were nonlocalizing by video-EEG monitoring. (a) The MRI scan is normal. (b) The ictal Tc-99m HMPAO brain
SPECT scan showed a focal area of signiﬁcant hyperemia in the right mesial frontal lobe. (c) There was minimal reduction of F-18 FDG
uptake in this location, but this was not speciﬁc for the identiﬁcation of the epileptogenic focus.
[32, 37–39]. Several articles published over the past decades
have compared interictal PET and ictal/interictal SPECT.
The limitation on the localization capability of interictal
FDG PET in extratemporal lobe epilepsy is illustrated by
Figure 9 in a case of a 42-year-old female with intractable
seizures with seizure activity frequency of 1-2 brief seizures
per day, felt to arise from the frontal lobe regions, but
were nonlocalizing by video-EEG monitoring. The patient
underwent an F-18 FDG brain PET scan which was nonlo-
calizing. An interictal Tc-99m-HMPAO brain SPECT scan8 International Journal of Molecular Imaging
(a) (b) (c) (d)
Figure 10: Eleven-year-old male suﬀering from generalized tonic-clonic seizure disorder. (a) MRI scan of an-11-year old boy suﬀering from
seizure disorder since the age of 7. The patient has tonic-clonic seizures. The MRI scan shows an arterial venous malformation in the right
parietal lobe. (b) The interictal brain F-18 FDG PET scan shows an area of reduced metabolic activity in the right parietal lobe consistent
with the location of the arterial venous malformation. (c) Images from an interictal Tc-99m ECD brain SPECT (top) as compared to an
ictal technetium-99m ECD brain SPECT scan (bottom). One can see signiﬁcant hyperemia anterior and inferior to the region of the arterial
venous malformation on the ictal Tc-99m ECD brain SPECT scan as compared to the interictal brain SPECT scan. (d) SISCOM analysis
where the ictal and interictal SPECT are compared and statistically signiﬁcant diﬀerences between the two are mapped onto the patient’s
MRI scan. One can see signiﬁcantly increased diﬀerences in the ictal study as compared to the interictal study in the anterior region and in
the location of the arterial venous malformation (highlighted yellow areas). The highlighted blue area shows areas of decreased uptake on
the ictal scan as compared to the interictal scan, which can generally be seen positioned randomly throughout the cortex and do not have
clinical or localizing signiﬁcance.
also showed minimal reduction in the frontal lobe, as well as
other areas of the brain. An ictal brain SPECT scan showed
signiﬁcant hyperemia in the right frontal lobe. The ﬁgure
shows a correlative image of the signiﬁcant hyperemia on
ictal SPECT as compared with nonspeciﬁc reduction on F-
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localizing. This scan illustrates the relative nonspeciﬁcity of
mild areas of reduction on F-18 FDG brain PET scan in
cases of frontal lobe epilepsy, and in these situations an
ictal Tc-99m HMPAO brain SPECT scan can provide greater
accuracy in diagnosis.
The importance of precise localization using a statis-
tical analysis method (such as SPM) and an automated
registration mapping method (such as AIR) is illustrated in
Figure 10 of a in 11-year-old male suﬀering from generalized
tonic-clonic seizure disorder since the age of 7. EEG showed
right parietooccipital focal slow and sharp waves. MRI
showed right parietooccipital cavernous venous angioma
with evidence of bleeding. An interictal SPECT scan shows
reduced perfusion in the region of the arterial venous
malformation, in addition to a large area around the lesion.
An F-18 FDG PET scan also shows reduction around
the large AVM area. Ictal SPECT showed hyperperfusion
in a region anterior and inferior to the AVM. This is
shown on a SPM analysis infusion scan correlating regional
cerebralperfusionwithaT1-weightedMRIscan.Thepatient
underwent electrocorticography and mapping of the lesion
for subsequent resection of the lesion and surrounding
epileptogenic area. On electrocorticography and mapping,
the area of increased epileptogenesis was found to correlate
with the ﬁndings of ictal SPECT.
8. Summary
The introduction of noninvasive neuroimaging methods,
such as single-photon emission computed tomography
(SPECT), positron emission tomography (PET), and mag-
netic resonance imaging (MRI), has dramatically changed
presurgical epilepsy evaluation. Previous studies have
demonstrated the diagnostic performance of each imaging
modality and the value of quantitative analysis of ictal
and interictal regional cerebral blood ﬂow SPECT and F-
18 FDG PET images. Overall, ictal SPECT has the highest
diagnostic sensitivity for both temporal and extratemporal
lobe epilepsy, and PET is known to have high sensitivity for
the evaluation of extratemporal lobe epilepsy. PET can be
employedasacomplimentaryimagingmodalitytoSPECTin
neocortical epilepsy. Quantitative image analysis can further
improve diagnostic accuracy of ictal and interictal SPECT
and F-18 FDG PET.
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